Glutamate transporter expression and function in human glial progenitors. 2004

Nicholas J Maragakis, and Joerg Dietrich, and Victor Wong, and Haipeng Xue, and Margot Mayer-Proschel, and Mahendra S Rao, and Jeffrey D Rothstein
Department of Neurology and Neuroscience, Johns Hopkins University, Meyer 6-109, 600 N. Wolfe Street, Baltimore, MD 21287-5953, USA.

Glutamate is the major neurotransmitter of the brain, whose extracellular levels are tightly controlled by glutamate transporters. Five glutamate transporters in the human brain (EAAT1-5) are present on both astroglia and neurons. We characterize the profile of three different human astroglial progenitors in vitro: human glial restricted precursors (HGRP), human astrocyte precursors (HAPC), and early-differentiated astrocytes. EAAT 1, EAAT3, and EAAT4 are all expressed in GRPs with a subsequent upregulation of EAAT1 following differentiation of GRPs into GRP-derived astrocytes in the presence of bone morphogenic protein (BMP-4). This corresponds to a significant increase in the glutamate transport capacity of these cells. EAAT2, the transporter responsible for the bulk of glutamate transport in the adult brain, is not expressed as a full-length protein, nor does it appear to have functional significance (as determined by the EAAT2 inhibitor dihydrokainate) in these precursors. A splice variant of EAAT2, termed EAAT2b, does appear to be present in low levels, however. EAAT3 and EAAT4 expression is reduced as glial maturation progresses both in astrocyte precursors and early-differentiated astrocytes and is consistent with their role in adult tissues as primarily neuronal glutamate transporters. These human glial precursors offer several advantages as tools for understanding glial biology because they can be passaged extensively in the presence of mitogens, afford the potential to study the temporal changes in glutamate transporter expression in a tightly controlled fashion, and are cultured in the absence of neuronal coculture, allowing for the independent study of astroglial biology.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D009435 Synaptic Transmission The communication from a NEURON to a target (neuron, muscle, or secretory cell) across a SYNAPSE. In chemical synaptic transmission, the presynaptic neuron releases a NEUROTRANSMITTER that diffuses across the synaptic cleft and binds to specific synaptic receptors, activating them. The activated receptors modulate specific ion channels and/or second-messenger systems in the postsynaptic cell. In electrical synaptic transmission, electrical signals are communicated as an ionic current flow across ELECTRICAL SYNAPSES. Neural Transmission,Neurotransmission,Transmission, Neural,Transmission, Synaptic
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005333 Fetus The unborn young of a viviparous mammal, in the postembryonic period, after the major structures have been outlined. In humans, the unborn young from the end of the eighth week after CONCEPTION until BIRTH, as distinguished from the earlier EMBRYO, MAMMALIAN. Fetal Structures,Fetal Tissue,Fetuses,Mummified Fetus,Retained Fetus,Fetal Structure,Fetal Tissues,Fetus, Mummified,Fetus, Retained,Structure, Fetal,Structures, Fetal,Tissue, Fetal,Tissues, Fetal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Nicholas J Maragakis, and Joerg Dietrich, and Victor Wong, and Haipeng Xue, and Margot Mayer-Proschel, and Mahendra S Rao, and Jeffrey D Rothstein
March 2015, Molecular therapy : the journal of the American Society of Gene Therapy,
Nicholas J Maragakis, and Joerg Dietrich, and Victor Wong, and Haipeng Xue, and Margot Mayer-Proschel, and Mahendra S Rao, and Jeffrey D Rothstein
October 2004, Brain pathology (Zurich, Switzerland),
Nicholas J Maragakis, and Joerg Dietrich, and Victor Wong, and Haipeng Xue, and Margot Mayer-Proschel, and Mahendra S Rao, and Jeffrey D Rothstein
January 2017, Advances in neurobiology,
Nicholas J Maragakis, and Joerg Dietrich, and Victor Wong, and Haipeng Xue, and Margot Mayer-Proschel, and Mahendra S Rao, and Jeffrey D Rothstein
August 2002, Journal of neurochemistry,
Nicholas J Maragakis, and Joerg Dietrich, and Victor Wong, and Haipeng Xue, and Margot Mayer-Proschel, and Mahendra S Rao, and Jeffrey D Rothstein
January 2007, The Journal of biological chemistry,
Nicholas J Maragakis, and Joerg Dietrich, and Victor Wong, and Haipeng Xue, and Margot Mayer-Proschel, and Mahendra S Rao, and Jeffrey D Rothstein
May 2007, Molecular and cellular neurosciences,
Nicholas J Maragakis, and Joerg Dietrich, and Victor Wong, and Haipeng Xue, and Margot Mayer-Proschel, and Mahendra S Rao, and Jeffrey D Rothstein
September 2003, Experimental neurology,
Nicholas J Maragakis, and Joerg Dietrich, and Victor Wong, and Haipeng Xue, and Margot Mayer-Proschel, and Mahendra S Rao, and Jeffrey D Rothstein
September 2002, The European journal of neuroscience,
Nicholas J Maragakis, and Joerg Dietrich, and Victor Wong, and Haipeng Xue, and Margot Mayer-Proschel, and Mahendra S Rao, and Jeffrey D Rothstein
December 1997, Brain research. Molecular brain research,
Nicholas J Maragakis, and Joerg Dietrich, and Victor Wong, and Haipeng Xue, and Margot Mayer-Proschel, and Mahendra S Rao, and Jeffrey D Rothstein
March 2005, Glia,
Copied contents to your clipboard!